First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.
Esen M, Fischer-Herr J, Gabor JJ, Gaile JM, Fleischmann WA, Smeenk GW, de Moraes RA, Bélard S, Calle CL, Woldearegai TG, Egger-Adam D, Haug V, Metz C, Reguzova A, Löffler MW, Balode B, Matthies LC, Ramharter M, Amann R, Kremsner PG.
Esen M, et al. Among authors: gabor jj.
Vaccines (Basel). 2024 Nov 18;12(11):1288. doi: 10.3390/vaccines12111288.
Vaccines (Basel). 2024.
PMID: 39591190
Free PMC article.